NO961429D0 - Fremgangsmåte for fremstilling av kinolonholdige, orale preparater - Google Patents

Fremgangsmåte for fremstilling av kinolonholdige, orale preparater

Info

Publication number
NO961429D0
NO961429D0 NO961429A NO961429A NO961429D0 NO 961429 D0 NO961429 D0 NO 961429D0 NO 961429 A NO961429 A NO 961429A NO 961429 A NO961429 A NO 961429A NO 961429 D0 NO961429 D0 NO 961429D0
Authority
NO
Norway
Prior art keywords
quinolone
preparation
oral preparations
containing oral
preparations
Prior art date
Application number
NO961429A
Other languages
English (en)
Norwegian (no)
Other versions
NO961429L (no
Inventor
Gabriel Gousset
Philippe Riviere
Original Assignee
Rhone Dpc Europ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Dpc Europ filed Critical Rhone Dpc Europ
Publication of NO961429D0 publication Critical patent/NO961429D0/no
Publication of NO961429L publication Critical patent/NO961429L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO961429A 1993-10-21 1996-04-11 Fremgangsmåte for fremstilling av kinolonholdige, orale preparater NO961429L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9312550A FR2711524B1 (fr) 1993-10-21 1993-10-21 Procédé de préparation de compositions orales contenant des quinolones.
PCT/FR1994/001212 WO1995011023A1 (fr) 1993-10-21 1994-10-19 Procede de preparation de compositions orales contenant des quinolones

Publications (2)

Publication Number Publication Date
NO961429D0 true NO961429D0 (no) 1996-04-11
NO961429L NO961429L (no) 1996-04-11

Family

ID=9452072

Family Applications (1)

Application Number Title Priority Date Filing Date
NO961429A NO961429L (no) 1993-10-21 1996-04-11 Fremgangsmåte for fremstilling av kinolonholdige, orale preparater

Country Status (29)

Country Link
US (1) US5840333A (fr)
EP (1) EP0724442A1 (fr)
AT (1) ATA905894A (fr)
AU (1) AU7997094A (fr)
BE (1) BE1007326A3 (fr)
CA (1) CA2174444A1 (fr)
CH (1) CH686555A5 (fr)
CO (1) CO4180603A1 (fr)
CZ (1) CZ113696A3 (fr)
DZ (1) DZ1818A1 (fr)
EE (1) EE9600050A (fr)
ES (1) ES2126474B1 (fr)
FI (1) FI961717A0 (fr)
FR (1) FR2711524B1 (fr)
GB (1) GB2297908B (fr)
GR (1) GR1002181B (fr)
HU (1) HUT74181A (fr)
IE (1) IE940838A1 (fr)
IT (1) IT1270672B (fr)
MA (1) MA23331A1 (fr)
NO (1) NO961429L (fr)
NZ (1) NZ274874A (fr)
OA (1) OA10282A (fr)
PL (1) PL314005A1 (fr)
SG (1) SG52202A1 (fr)
SK (1) SK50596A3 (fr)
TN (1) TNSN94110A1 (fr)
WO (2) WO1995011023A1 (fr)
ZA (1) ZA948175B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177101B1 (en) * 1998-06-11 2001-01-23 Pharmacia & Upjohn Company Delavirdine high strength tablet formulation
US6342598B1 (en) 1998-11-26 2002-01-29 Bracco International B.V. Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents
CN102499928A (zh) 2004-08-13 2012-06-20 先灵-普劳有限公司 包含抗菌素、三唑和皮质类固醇的药物制剂

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
JPH01175936A (ja) * 1987-12-28 1989-07-12 Kyorin Pharmaceut Co Ltd 6.8−ジフルオロ−1−(2−フルオロエチル)−1,4−ジヒドロ−7−(4−メチル−1−ピペラジニル)−4−オキソ−3−キノリンカルボン酸を有効成分とする錠剤
US4973470A (en) * 1989-06-26 1990-11-27 Warner-Lambert Company Sustained release pharmaceutical compositions
JPH10175936A (ja) * 1996-12-17 1998-06-30 Kao Corp 新規アミドアミノポリカルボン酸又はその塩、及びそれを含有する洗浄剤組成物

Also Published As

Publication number Publication date
OA10282A (fr) 1997-10-07
GB9608316D0 (en) 1996-06-26
WO1995011023A1 (fr) 1995-04-27
HUT74181A (en) 1996-11-28
ZA948175B (en) 1995-06-08
NZ274874A (en) 1997-10-24
GB2297908B (en) 1997-12-10
US5840333A (en) 1998-11-24
FI961717A (fi) 1996-04-19
ES2126474B1 (es) 1999-11-16
FI961717A0 (fi) 1996-04-19
DZ1818A1 (fr) 2002-02-17
EP0724442A1 (fr) 1996-08-07
FR2711524B1 (fr) 1995-11-24
ES2126474A1 (es) 1999-03-16
CZ113696A3 (en) 1996-07-17
GB2297908A (en) 1996-08-21
SK50596A3 (en) 1997-02-05
FR2711524A1 (fr) 1995-05-05
CO4180603A1 (es) 1995-06-07
EE9600050A (et) 1996-10-15
BE1007326A3 (fr) 1995-05-16
MA23331A1 (fr) 1995-04-01
IE940838A1 (en) 1995-05-03
AU7997094A (en) 1995-05-08
HU9601041D0 (en) 1996-06-28
SG52202A1 (en) 1998-09-28
CA2174444A1 (fr) 1995-04-27
GR1002181B (en) 1996-03-12
ITMI942130A0 (it) 1994-10-19
IT1270672B (it) 1997-05-07
NO961429L (no) 1996-04-11
CH686555A5 (fr) 1996-04-30
ITMI942130A1 (it) 1996-04-19
PL314005A1 (en) 1996-08-05
TNSN94110A1 (fr) 1995-09-21
ATA905894A (de) 2000-06-15
WO1995011022A1 (fr) 1995-04-27

Similar Documents

Publication Publication Date Title
NO913234D0 (no) Fremgangsmaate for fremstilling av pyrazolderivater.
NO904987D0 (no) Fremgangsmaate for fremstilling av indolderivater.
NO961006D0 (no) Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
NO912346D0 (no) Fremgangsmaate for fremstilling av aminobenzodiazepiner.
FI940769A (fi) Menetelmä 2-aminoatsolijohdannaisten valmistamiseksi
NO982237L (no) FremgangsmÕte for fremstilling av fenylimidazolidinderivater
NO903431D0 (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903275L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO905377L (no) Fremgangsmaate for fremstilling av glycerolderivater.
NO903043L (no) Fremgangsmaate for fremstilling av kromanderivater.
NO903207L (no) Fremgangsmaate for fremstilling av halogenaminoaromatiske derivater.
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
NO941056L (no) Fremgangsmåte for fremstilling av organoklorsilaner
NO961429D0 (no) Fremgangsmåte for fremstilling av kinolonholdige, orale preparater
NO902762D0 (no) Fremgangsmaate for fremstilling av 5-fenyl-2-furan derivater.
NO920636L (no) Fremgangsmaate for fremstilling av 9-amino-1,2,3,4-tetra-hydroakridin
NO179101C (no) Fremgangsmåte for fremstilling av dibeskyttet 2,3-hydroksymetyl-cyklobutanol
NO931839D0 (no) Fremgangsmaate for fremstilling av pergolid
NO911672D0 (no) Fremgangsmaate for fremstilling av alkansulfonanilid-derivater.
NO972129D0 (no) Fremgangsmåte for fremstilling av 1-halo-3-trialkylsilanyl-benzenderivater
NO905047L (no) Fremgangsmaate for fremstilling av selenofenderivater.
NO964519D0 (no) Fremgangsmåte for fremstilling av chitosanalkylderivater
NO913429D0 (no) Fremgangsmaate for fremstilling av 5-benzyl-substituerte benzimidazolin-2-tion-derivater.
FI933004A (fi) Menetelmä N-alkyyli-3,4-dialkyylioksianiliinien ja niiden johdannaisten valmistamiseksi